The FDA has approved the VNS Therapy (LivaNova) in patients as young as four years of age with partial onset refractory seizures. Originally approved for patients ages 12 years and older, VNS Therapy is a minimally invasive treatment option designed to prevent seizures before they start. “Epilepsy can be a very trying and debilitating disease that can hold a child back from reaching his or her full potential,” said Damien McDonald, LivaNova’s Chief Executive Officer. “Children with frequent seizures require urgent and careful treatment to prevent further delay in their development.”Next Story
VNS Therapy Approved in Children Ages Four Years and Older with Partial Onset Refractory Seizures
Friday, June 30, 2017
You must be logged in to leave a comment.